Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Couttas

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Translational Psychiatry|May 28, 2026
Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disordersTimothy A Couttas, Anna E Hoffmann, Beverly Jieu, et al.
Neurobiology of Aging|June 4, 2016
Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer's diseaseTimothy A Couttas, Nupur Kain, Alexandra K Suchowerska, et al.
Psychiatry Research|July 1, 2024
Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiolBeverly Jieu, Eliska B Sykorova, Cathrin Rohleder, et al.
Journal of Lipid Research|August 15, 2019
High FA2H and UGT8 transcript levels predict hydroxylated hexosylceramide accumulation in lung adenocarcinomaAnne-Marie Lemay, Olivier Courtemanche, Timothy A Couttas, et al.
Cannabis and Cannabinoid Research|May 17, 2022
Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and <i>N</i>-Acylethanolamines by Liquid Chromatography-Tandem Mass SpectrometryTimothy A Couttas, Carola Boost, Franziska Pahlisch, et al.
Acta Neuropathologica Communications|January 25, 2014
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesisTimothy A Couttas, Nupur Kain, Benjamin Daniels, et al.
Journal of Neurochemistry|November 20, 2019
Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytesCollin Tran, Benjamin Heng, Jonathan D Teo, et al.
Oncotarget|April 13, 2018
Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated miceJinbiao Chen, Yanfei Qi, Yang Zhao, et al.
Scientific Reports|February 22, 2024
ReTimeML: a retention time predictor that supports the LC-MS/MS analysis of sphingolipidsMichael Allwright, Boris Guennewig, Anna E Hoffmann, et al.
Ebiomedicine|March 26, 2025
Cerebrospinal fluid metabolomics in autistic regression reveals dysregulation of sphingolipids and decreased β-hydroxybutyrateJingya Yan, Velda X Han, Hannah F Jones, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Translational Psychiatry|May 28, 2026
Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disordersTimothy A Couttas, Anna E Hoffmann, Beverly Jieu, et al.
Neurobiology of Aging|June 4, 2016
Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer's diseaseTimothy A Couttas, Nupur Kain, Alexandra K Suchowerska, et al.
Psychiatry Research|July 1, 2024
Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiolBeverly Jieu, Eliska B Sykorova, Cathrin Rohleder, et al.
Journal of Lipid Research|August 15, 2019
High FA2H and UGT8 transcript levels predict hydroxylated hexosylceramide accumulation in lung adenocarcinomaAnne-Marie Lemay, Olivier Courtemanche, Timothy A Couttas, et al.
Cannabis and Cannabinoid Research|May 17, 2022
Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and <i>N</i>-Acylethanolamines by Liquid Chromatography-Tandem Mass SpectrometryTimothy A Couttas, Carola Boost, Franziska Pahlisch, et al.
Acta Neuropathologica Communications|January 25, 2014
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesisTimothy A Couttas, Nupur Kain, Benjamin Daniels, et al.
Journal of Neurochemistry|November 20, 2019
Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytesCollin Tran, Benjamin Heng, Jonathan D Teo, et al.
Oncotarget|April 13, 2018
Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated miceJinbiao Chen, Yanfei Qi, Yang Zhao, et al.
Scientific Reports|February 22, 2024
ReTimeML: a retention time predictor that supports the LC-MS/MS analysis of sphingolipidsMichael Allwright, Boris Guennewig, Anna E Hoffmann, et al.
Ebiomedicine|March 26, 2025
Cerebrospinal fluid metabolomics in autistic regression reveals dysregulation of sphingolipids and decreased β-hydroxybutyrateJingya Yan, Velda X Han, Hannah F Jones, et al.
Pageof 3